Total submissions: 6
Submitter | RCV | SCV | Clinical significance | Condition | Last evaluated | Review status | Method | Comment |
---|---|---|---|---|---|---|---|---|
Eurofins Ntd Llc |
RCV000081462 | SCV000113393 | benign | not specified | 2013-05-20 | criteria provided, single submitter | clinical testing | |
Prevention |
RCV000081462 | SCV000311587 | benign | not specified | criteria provided, single submitter | clinical testing | ||
Gene |
RCV000081462 | SCV000533555 | likely benign | not specified | 2018-02-13 | criteria provided, single submitter | clinical testing | This variant is considered likely benign or benign based on one or more of the following criteria: it is a conservative change, it occurs at a poorly conserved position in the protein, it is predicted to be benign by multiple in silico algorithms, and/or has population frequency not consistent with disease. |
Labcorp Genetics |
RCV000541018 | SCV000638806 | benign | Myofibrillar myopathy 3 | 2025-01-28 | criteria provided, single submitter | clinical testing | |
Athena Diagnostics | RCV000081462 | SCV001476560 | benign | not specified | 2024-07-05 | criteria provided, single submitter | clinical testing | |
Women's Health and Genetics/Laboratory Corporation of America, |
RCV000081462 | SCV005726245 | benign | not specified | 2024-11-15 | criteria provided, single submitter | clinical testing |